Rapid recovery from acute, potentially lethal myocarditis

Journal of International Medical Research

Volumn 37, Issue 5, 2009, Pages 1522-1525

  Eleftheriou, A E ^a   Stamatelopoulos, S F ^a  

^a HENRY DUNANT HOSPITAL   (Greece)

Author keywords

Intravenous immunoglobulin (IV IG); Myocarditis; Recovery

Indexed keywords

IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT;

ACUTE DISEASE; ADULT; ARTICLE; CASE REPORT; HUMAN; IMMUNOLOGY; MALE; MYOCARDITIS; PROGNOSIS; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYOCARDITIS; PROGNOSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77649214468     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/147323000903700530     Document Type: Article

References (16)

1. Haas GJ: Etiology evaluation and management of acute myocarditis. Cardiol Rev 2001; 9: 88-95.
2. Howes DS, Booker EA: Myocarditis. e Medicine Emergency Medicine, 5 Aug 2008 (available at http://emedicine.medscape.com/article/759212-overview
3. Riera Sagrera M, Fiol Sala M, Pérez Bárcena J, et al: Acute myocarditis and left ventricular "hypertrophy". Echocardiography 2000; 17(6 part 1): 567-570.
4. Winkel E, Costanzo MR, Parrillo J: Myocarditis. Curr Treat Options Cardiovasc Med 2000; 2: 407-419.
5. Mason J, O'Conell J, Herskowitz A, et al: A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995; 333: 269-275.
6. Kishimoto C, Shiojik K, Kinostitu M, et al: Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress. Int J Cardiol 2003; 91: 173-178.
7. Sole MJ, Liu P: Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. J Am Coll Cardiol 1993; 22(4 suppl A): 99A-105A.
8. Morgera T, Di Lenarda A, Dreas L, et al: Electrocardiography of myocarditis revisited: Downloaded from imr.sagepub.com by Michiel Schotten on April 14, 2013 clinical and prognostic significance of electrocardiographic changes. Am Heart J 1992; 124: 455-467.
9. Mendes LA, Picard MH, Dec GW, et al: Ventricular remodeling in active myocarditis. Myocarditis Treatment Trial. Am Heart J 1999; 138(2 part 1): 303-308.
10. Fuse K, Kodama M, Okura Y, et al: Predictors of disease course in patients with acute myocarditis. Circulation 2000; 102: 2829-2835.
11. Nishio R, Shioi T, Sasayama S, et al: Carvedilol increases the production of interleukin-12 and interferon-γ and improves the survival of mice infected with the encephalomyocarditis virus. J Am Coll Cardiol 2003; 41: 340-345.
12. Rezkalla SH, Raikar S, Kloner RA: Treatment of viral myocarditis with focus on captopril. Am J Cardiol 1996; 77: 634-637.
13. Gowrishankan K, Rajajee S: Varied manifestations of viral myocarditis. Indian J Pediatr 1994; 61: 75-80.
14. McNamara DM, Halubkov R, Starling RC: Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001; 103: 2254-2259.
15. Takada H, Kishimoto C, Hiraoka Y: Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects. Circulation 1995; 92: 1604-1611.
16. Tedeschi A, Airaghi L, Giannini S, et al: Highdose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature. J Intern Med 2002; 251: 169.